Last reviewed · How we verify
AX-158
At a glance
| Generic name | AX-158 |
|---|---|
| Also known as | Placebo |
| Sponsor | Artax Biopharma Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis (PHASE1, PHASE2)
- A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AX-158 CI brief — competitive landscape report
- AX-158 updates RSS · CI watch RSS
- Artax Biopharma Inc portfolio CI